Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination. (Q51890555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

P A Kozlowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

S-W Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

R L Wilson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

E Micewicz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

D C Montefiori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

K G Mansfield

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A Carville

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A Aldovini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

9 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

536-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/mi.2009.103

7 February 2020

exact match

0 references

cites work

Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Magnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Prospects for vaccine protection against HIV-1 infection and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: views over hidden possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

7 January 2021

Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

7 January 2021

Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

7 January 2021

Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody

1 reference

https://api.crossref.org/works/10.1038%2FMI.2009.103

7 January 2021

Identifiers

DOI

10.1038/MI.2009.103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19741603%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference